PARP inhibitors Choosing what to use in epithelial ovarian cancer: Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
- Resource Type
- Academic Journal
- Source
Contemporary OB/GYN (CONTEMP OB GYN), Apr2020; 65(4): 30-36. (6p)- Subject
- Language
- English
- ISSN
- 0090-3159